Comparing the current results to its competitors, Immucell reported Revenue increase in the 2 quarter 2026 by 11.5 % year on year. The sales growth was above Immucell's competitors' average revenue growth of 8.32 %, achieved in the same quarter.
Immucell Corporation Net Income in the 2 quarter 2026 grew year on year by 265.56%, faster than the Immucell's competitors average income growth of 16.9 %
Company's competitiveness improved within Overall company, with revenue growth of 11.5 % and its market share increased to approx. 0.57 %. << More on ICCC Market Share.
*Market share is calculated based on total revenue.
June 5, 2024
PORTLAND, Maine, June 05, 2024 - ImmuCell Corporation (Nasdaq: ICCC), a burgeoning animal health company, is making waves with its latest regulatory update on its product development initiative for Re-Tain. Here are the key points you need to know about this potentially transformative development. Re-Tain: A Quick Overview Re-Tain is a promising product developed by ImmuCell aimed at enhancing the health and productivity of dairy and beef cattle. The product focuses on treating subclinical mastitis a significant issue in dairy production that can severely impact milk yield and overall herd health. Subclinical mastitis is a stealthy disease typically not visible to the naked eye but can cause substantial fin...
Elanco Animal Health Incorporated Share Performance
+1.62%
Over The Past 5 Days
Elanco Animal Health Incorporated
Profile
Elanco Animal Health Inc operates on a business model that focuses on the development, manufacturing, and marketing of veterinary products and services. They aim to provide innovative solutions for animal health and well-being, offering a range of products including medicines, vaccines, and feed additives. Elanco serves both companion animals and food-producing animals, catering to the diverse needs of veterinarians, farmers, and pet owners worldwide.
Idexx Laboratories Inc operates within the veterinary diagnostics industry, offering a comprehensive suite of innovative products and services tailored for veterinary practices globally. Their business model focuses on the development and manufacture of diagnostic tests, instruments, and software solutions that assist in the detection and management of animal health issues. Revenue is primarily generated through direct sales of these products to veterinarians, clinics, and laboratories, enhancing the quality of animal care through advanced diagnostic capabilities.
Neogen Corporation operates on a business model focused on developing and marketing various solutions for food and animal safety. They offer a wide range of products and services, including diagnostic tests, disinfectants, and animal genomics, catering to customers in the agricultural, food processing, and veterinary industries. By continually innovating and meeting industry regulations, Neogen Corporation aims to improve the safety and quality of food and animal products globally.
Zoetis Inc operates as a global animal health company, offering a comprehensive range of medicines, vaccines, diagnostics, and services for both livestock and companion animals. Their business model emphasizes innovation in research and development to improve animal health, coupled with strong customer support, educational resources, and targeted solutions for veterinarians, livestock producers, and pet owners around the world.
Sources:
Immucell Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Immucell Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
